Patrick J. Stuebgen, M.B.,Ch.B., M.D.
Neurology
Publications
Articles:
1. Stubgen JP, Lotz BP: Isolated angiitis of the central nervous system: Involvement of vessels at the base of the brain. J Neurol 1991; 238:235-239.
2. Stubgen JP, Lotz BP: Segmental ballistic movement overflow myoclonus. A clinical, electromyographic and pharmacologic evaluation. Mov Disord 1991; 6:350-353.
3. Stubgen JP: Myopathy and neuropathy due to tuberculous vasculitis. S Afr Med J 1992; 81:436-437 (letter).
4. Stubgen JP, Lotz BP: Membranous lipodystrophy. Clinical and electrophysiological observations in the first South African case. S Afr Med J 1992; 81:620-622.
5. Lotz BP, Stubgen JP: The Rigid Spine Syndrome: a vacuolar variant. Muscle Nerve 1993; 16:530-536.
6. Stubgen JP: Isolated angiitis of the central nervous system. S Afr Med J 1993; 83: 618-620 (letter).
7. Stubgen JP: Limb girdle muscular dystrophy: a non-invasive cardiac evaluation. Cardiology 1993; 83:324-330.
8. Stubgen JP, Ras G, Schultz C, Crowther G: Lung and respiratory muscle function in limb girdle muscular dystrophy. Thorax 1994; 49:61-65.
9. Stubgen JP, Lahouter A: Limb girdle muscular dystrophy: weakness and disease duration as predictors of functional impairment. Muscle Nerve 1994; 17:873-880.
10. Ras GJ, van Staden M, Schultz C, Stubgen JP, Lotz BP, van der Merwe C: Respiratory manifestations of the rigid spine syndrome. Am J Respir Crit Care Med 1994; 150:540-546.
11. Stubgen JP: Limb girdle muscular dystrophy: description of a phenotype. Muscle Nerve 1994; 17:1449-1455.
12. Stubgen JP, Bartel PR: Multimodal evoked potentials and electroretinography in limb girdle muscular dystrophy. Electromyogr Clin Neurophysiol 1995; 35:31-38.
13. Stubgen JP: Limb girdle muscular dystrophy: a quantitative electromyographic study. Electrmyogr Clin Neurophysiol 1995; 35:351-357.
14. Stubgen JP: Intra-ventricular blood after "traumatic" lumbar puncture. Childs Nerv Syst 1995; 11:492-493.
15. Stubgen JP: Neurosarcoidosis presenting as a retro-clival tumor. Surg Neurol 1995; 43:85-88.
16. Stubgen JP: Crossed cerebellar diaschisis related to recurrent focal seizures. Epilepsia 1995; 36:316-318.
17. Stubgen JP: Neuromuscular disorders in systemic malignancy and its treatment. Muscle Nerve 1995; 18:636-648.
18. Stubgen JP: Limb girdle muscular dystrophy: a radiologic and manometric study of the pharynx and esophagus. Dysphagia 1996; 11:25-29.
19. Stubgen JP: T12 epidural metastasis mimicks pelvic recurrence of cecal adenocarcinoma. J Pain Symptom Manage 1996; 11:61-64.
20. Stubgen JP: Neuromuscular disorders in systemic malignancy and its treatment. Muscle Nerve 1996; 19:110 (letter).
21. Stubgen JP: Crossed cerebellar diaschisis related to recurrent focal seizures. Epilepsia 1996; 37:418 (letter).
22. Stubgen JP: Crossed cerebellar diaschisis related to recurrent focal seizures. Search on Epilepsy 1996; 3:10-12.
23. Stubgen JP: Neuromuscular disorders in systemic malignancy and its treatment. Muscle Nerve 1996; 19:1363-1364 (letter).
24. Stubgen JP, Stipp A: Limb girdle muscular dystrophy: a prospective follow-up study of functional impairment. Muscle Nerve 1997; 20:453-460.
25. Delanty N, Vaughan C, Frucht S, Stubgen JP: Erythropoietin-associated hypertensive posterior leukoencephalopathy. Neurology 1997; 49:686-689.
26. Stubgen JP: Neuromuscular disorders in systemic malignancy. Current Opinion in Neurology 1997; 10:371-375.
27. Stubgen JP: Nervous system lupus mimics limbic encephalitis. Lupus 1998; 7:557-560.
28. Delanty N, Georgescu L, Lynch T, Paget S, Stubgen JP: Synovial fluid PCR as an aid to the diagnosis of CNS Whipple's disease. Ann Neurol 1999; 45:137-138.
29. Stubgen JP: Initial management of the comatose patient: practical considerations. Hospital Medicine 1999; 35:51-57.
30. Caronna JJ, Stubgen JP: Predicting mortality in ICU patients with stroke. Crit Care Med 2000; 28:1656-1657 (editorial).
31. Bruno MK, Winterkorn JMS, Edgar MA, Kamal A, Stubgen JP: Unilateral Adie's pupil as sole ophthalmologic manifestation of anti-Hu paraneoplastic syndrome. Journal of Neuro-Ophthalmology 2000; 20:248-249.
32. Stubgen JP. Rigid spine syndrome (vacuolar variant). A quantitative electromyographic study. Electromyogr clin Neurophysiol 2007; 47: 55-60.
33. Stubgen JP. Facioscapulohumeral muscular dystrophy. A quantitative electromyograhic study. Electromyogr clin Neurophysiol 2007; 47:175-182.
34. Stubgen JP. Facioscapulohumeral muscular dystrophy. Multimodal evoked potentials and electroretinogram. Electromyogr clin Neurophysiol 2007; 47:233-241
35. Stubgen JP. Rigid spine syndrome. A non-invasive cardiac evaluation. Pediatr Cardiol 2008; 29:45-49.
36. Stubgen JP. Rigid spine syndrome. A radiologic and manometric study of the pharynx and esophagus. Dysphagia 2008; 23:110-115.
37. Stubgen JP. Tumor necrosis factor alpha- antagonists and neuropathy. Muscle Nerve 2008;37:281-292.
38. Stubgen JP. Limb Girdle muscular dystrophy. An interval study of weakness and functional impairment. J Clin Neuromusc Dis 2008; 9:333-340.
39. Stubgen JP. Facioscapulohumeral muscular dystrophy. A radiologic and manometric study of the pharynx and esophagus. Dysphagia 2008; 23:341-347.
40. Stubgen JP.The effects of recombinant type I interferon therapy on human muscle diseases. Muscle & Nerve 2009 Aug 7. [Epub ahead of print].
41. Stubgen JP. B cell-targeted therapy with rituximab and autoimmune neuromuscular disorders. J Neuroimmunol 2008; 204:1-12.
42. Stubgen JP, Schultz C. Lung and respiratory muscle function in facioscapulohumeral muscular dystrophy. Muscle Nerve 2009; 39:729-734.
43. Stubgen JP. Interferon alpha and neuromuscular disorders. J Neuroimmunol 2009; 207:3-17.
44. Stubgen JP. Recombinant interferon-beta therapy and neuromuscular disorders. J Neuroimmunol 2009; 212:132-141.
45. Stubgen JP. Central nervous system inflammatory demyelination after rituximab therapy for idiopathic thrombocytopenic purpura. J Neurol Sci 2010; 288:178-181.
46. Stubgen JP. Neuromuscular disorders associated with hepatitis B vaccination. J Neurol Sci 2010;292:1-4.
47. Stubgen JP. Unilateral macroglossia as sole presenting manifestation of internal carotid artery dissection. Ear Nose Throat J 2011; 90:434-436.
48. Stubgen JP. Neuromuscular disorders associated with chronic hepatitis C virus infection. J Clin Neuromusc Dis 2011; 13:14-25.
49. Stubgen JP, Stipp A. Facioscapulohumeral muscular dystrophy: a prospective study of weakness and functional impairment. J Neurol 2010;257:1457-1464.
50. Stubgen JP. Neuromuscular disorders associated with hepatitis B virus infection. J Clin Neuromusc Dis 2011; 13:26-37.
51. Patsalides A, Tzatha E, Stubgen JP, Shungu DC, Stieg PE, Gobin YP. Intracranial dural arteriovenous fistula presenting as an enhancing lesion of the medulla. J Neurointervent Surg 2010;2:390-393.
52. Stubgen JP. Neuromuscular complications of hepatitis A virus infection and vaccines. J Neurol Sci 2011;300:2-8.
53. Stubgen JP. Reversible, chronic homonymous hemianopia due to a suprasellar cyst in an elderly patient. Clin Geriatrics 2011;19:57-60.
54. Stubgen JP. Tumor necrosis factor alpha as a potential therapeutic target in idiopathic inflammatory myopathy. J Neurol 2011;258:961-970.
55. Stubgen JP. Drug-induced dysimmune demyelinating neuropathies. J Neurol Sci 2011; 307:1-8.
56. Stubgen JP. Immune-mediated myelitis associated with Hepatitis virus infections. J Neuroimmunol 2011; 239:21-27.
57. Stubgen JP. Subacute encephalopathy associated with aquaporin-4 autoantibodies. A report of 2 adult cases. Clin Neurol Neurosurg 2012;114:1110-1113.
58. Stubgen JP. Immune-mediated myelitis following hepatitis B vaccination. Autoimmun Rev 2012;12:144-149.
59. Stubgen JP. targeted immunotherapy trials for idiopathic inflammatory myopathies. J Neurol 2013;260:368-385.
60. Stubgen JP. Posterior reversible encephalopathy (PRES) after granulocyte-colony stimulating factor (G-CSF). A report of 2 cases. J Neurol Sci 2012;321:35-38.
61. Stubgen JP. A review of the use of biological agents for chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Sci 2013;326:1-9.
62. Stubgen JP. A literature review on optic neuritis following vaccination against virus infections. Autoimmun Rev 2013 Mar 26 [Epub ahead of print]
63. Stubgen JP. Biological agents for chronic inflammatory demyelinating polyradiculoneuropathy. Eur Neurol Rev 2013 (in press).
Book chapters:
1. Stubgen JP, Caronna JJ: Coma, in Parrillo JE (ed). Current Therapy in Critical Care Medicine. (3rd edition), Mosby, St. Louis, 1997, pp306-310.
2. Stubgen JP, Elliot KJ: Malignant radiculopathies and plexopathies, in Vinken PJ, Bruyn GW (eds). Handbook of Clinical Neurology. Neuro-Oncology Part III, Elsevier, Amsterdam, 1997, Volume 69, pp71-103 .
3. Stubgen JP, Caronna JJ: Altered Mental Status, in Samuels MA (ed). Hospitalist Neurology. Butterworth-Heineman, 1999, pp 27-43.
4. Stubgen JP: Craniocervical Junction Abnormalities (Chapter Neu 18) and Muscular Dystrophies and other Myopathies (Chapter Neu 21), in Berkow R (ed). The Merck Manual, 17th Ed. Merck & Co., Inc., Rahway NJ, 1999.
5. Stubgen JP, Plum F: Evaluation of the comatose patient, in Grenvik A, Ayres SM, Holbrook PR, Shoemaker WC (eds). Textbook of Critical Care, 4th Ed. WB Saunders Company, Philadelphia, 2000, pp1831-1845.
6. Stubgen JP: Seizures in multi-system disease affecting the nervous system, in Delanty N (ed). Seizures: Medical Causes and Management. The Humana Press Inc, 2002, pp49-70.
7. Stubgen JP, Caronna JJ: Coma, in Parillo JE, Dellinger RP (eds). Critical Care Medicine: Principles of Diagnosis and Treatment. 2nd Ed. WB Saunders Company, Philadelphia, 2001, pp1259-1277.
8. Stubgen JP, Plum F: Coma, in Fink MP, Abraham E, Kochanek PM, Vincent J-L (eds). Textbook of Critical Care, 5th Ed. Elsevier Saunders, Philadelphia, 2005, pp 295-309).
9. Stübgen J-P, Plum F, Kochanek PM: Coma. In: Vincent J-L, Abraham E, Moore FA, Kochanek PM, Fink MP (eds). Textbook of Critical Care, 6th Ed. Elsevier Saunders, Philadelphia, 2011, pp 153-165.
